Mortality and Lung Function Decline of Idiopathic Pulmonary Fibrosis Patient with Ezetimibe and Pirfenidone

Conclusions: Ezetimibe may decrease the mortality and lung function decline in IPF patients. But furthur prospective validation clinical study is required.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Cho, J., Lee, C., Kwak, S. H., Kim, Y. S. Tags: Idiopathic interstitial pneumonias Source Type: research